{"id":3884,"date":"2018-02-07T17:00:10","date_gmt":"2018-02-07T22:00:10","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=3884"},"modified":"2018-02-07T17:00:10","modified_gmt":"2018-02-07T22:00:10","slug":"secondaries-announced-2-7-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/secondaries-announced-2-7-18\/","title":{"rendered":"Secondaries Announced 2.7.18"},"content":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis.<\/strong><\/h4>\n

If having\u00a0real-time alerts for secondary offerings<\/strong><\/a>\u00a0would be an advantage to you,\u00a0inquire about a subscription today!<\/a><\/p>\n

Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis. For example, this is not to be interpreted as a Buy recommendation in the traditional sense of adding to your stock portfolio; this is a short term (usually one day or opening trade) time period.<\/p>\n

Company: MedicNova, Inc.<\/strong>
\nSymbol: MNOV
\nPrice: Last Trade $9.73
\nTrade Date: 2\/8
\nShares: 4.3 million ($40 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Ladenburg Thalmann
\nCo-Manager(s): B.Riley FBR
\nDescription: They are a publicly-traded biopharmaceutical company founded upon acquiring and developing novel, small-molecule therapeutics for the treatment of diseases with unmet medical needs with a primary commercial focus on the U.S. market.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Viveve Medical, Inc.
\nSymbol: VIVE
\nPrice: Last Trade $3.83
\nTrade Date: 2\/8
\nShares: 7.9 million ($30m cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Cowen
\nDescription: They are a medical technology company focused on women’s intimate health
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Sage Therapeutics, Inc.
\nSymbol: SAGE
\nPrice: Last Trade $177.38
\nTrade Date: 2\/9
\nShares: 3.3 million ($575 million cash raise)
\nUnderwriter(s): J.P. Morgan, Goldman Sachs, Morgan Stanley
\nDescription: They are a clinical-stage biopharmaceutical company committed to developing novel medicines to transform the lives of patients with life-altering central nervous system (CNS) disorders.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Adverum Biotechnologies
\nSymbol: ADVM
\nPrice: Last Trade $7.10
\nTrade Date: 2\/8
\nShares: 7.1 million ($50 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Cowen, Piper Jaffray
\nCo-Manager(s): Raymond James
\nDescription: They are a clinical-stage gene therapy company targeting unmet medical needs in serious rare and ocular diseases.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Everspin Technologies, Inc.
\nSymbol: MRAM
\nPrice: Last Trade $8.68
\nTrade Date: 2\/8
\nShares: 3.5 million ($25 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Stifel
\nDescription: They are the worldwide leader in designing, manufacturing, and commercially shipping discrete and embedded MRAM into markets and applications where data persistence, performance, and endurance are paramount.
\nRating =Subscription Needed<\/a><\/strong><\/p>\n

Company: Gemphire Therapeutics, Inc.
\nSymbol: GEMP
\nPrice: Last Trade $8.63
\nTrade Date: 2\/8
\nShares: 2.86 million ($20 million cash raise)
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Piper Jaffray
\nCo-Manager: Raymond James
\nDescription: They are a clinical-stage biopharmaceutical company that is committed to helping patients with cardiometabolic disorders, including dyslipidemia and NASH.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Oaktree Capital Group LLC-BLOCK
\nSymbol: OAK
\nPrice: Last Trade $45.65
\nTrade Date: 2\/8
\nShares: 5 million
\nRe-Offer Range: Subscription Needed<\/a><\/strong>
\nUnderwriter(s): Morgan Stanley
\nDescription: Oaktree Capital Management is an American global asset management firm specializing in alternative investment strategies.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n

Company: Cadence Bancorporation
\nSymbol: CADE
\nPrice: Last Trade $26.96
\nTrade Date: 2\/9
\nShares: 7 million
\nUnderwriter(s): Goldman Sachs, J.P. Morgan, Keefe Bruyette & Woods, Sandler O\u2019 Neill + Partners
\nCo-Manager(s): Baird, Raymond James, RBC Capital, Stephens Inc.
\nDescription: They are a bank holding company and a Delaware corporation headquartered in Houston, Texas, and is the parent company of Cadence Bank.
\nRating = Subscription Needed<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"

IPO BOUTIQUE CLIENTS\u00a0and\u00a0IPO BOUTIQUE SECONDARY ALERTS CLIENTS\u00a0received ALL this information to their inbox on a\u00a0REAL TIME\u00a0basis. If having\u00a0real-time alerts for secondary offerings\u00a0would be an advantage to you,\u00a0inquire about a subscription today! Our Buy, Neutral or Avoid ratings of the Secondaries below are intended as a recommendation for those who buy Secondaries on a regular basis.[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[35],"tags":[],"class_list":["post-3884","post","type-post","status-publish","format-standard","hentry","category-secondary-offerings"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3884","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=3884"}],"version-history":[{"count":1,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3884\/revisions"}],"predecessor-version":[{"id":3885,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/3884\/revisions\/3885"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=3884"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=3884"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=3884"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}